#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	12726	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2053	612.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	787	C,A,G	767,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23324	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3639	635.8	0	.	n	.	0	T695C	SNP	695	695	T	1040	1040	C	728	C,G	695,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23324	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3639	635.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1682	1682	A	745	A,G	721,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23324	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3639	635.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2316	2316	C	753	C,T	732,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23324	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3639	635.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2390	2390	A	665	A	642	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23324	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3639	635.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2942	2942	C	742	C,T	713,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	36006	blaTEM	861	861	100.0	blaTEM.l15.c17.ctg.1	1438	2473.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_L_00516	folP.WHO_L_00516	1	1	539	1548	folP	855	855	99.88	folP.l15.c4.ctg.1	1571	97.9	1	SNP	p	R229S	1	R229S	NONSYN	685	687	CGC	1053	1055	AGC	134;134;134	A;G;C	131;130;131	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	4154	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3551	116.0	0	.	p	.	0	G95A	NONSYN	283	285	GGC	763	765	GCC	143;141;142	G,C;C;C,T	137,1;134;137,1	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	4154	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3551	116.0	1	SNP	p	S91F	1	.	.	271	273	TTC	751	753	TTC	145;145;143	T;T;C	140;139;139	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1284	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1357	94.0	1	SNP	p	G45D	0	.	.	133	135	GGC	477	479	GGC	137;135;134	G;G;C	136;133;130	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	642	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	807	77.1	0	.	n	.	0	A197.	DEL	197	197	A	504	504	A	144	A	138	.	.
parC.WHO_L_00611c	parC.WHO_L_00611c	1	1	27	4308	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2889	147.6	1	SNP	p	S87I	0	.	.	259	261	AGT	538	540	AGT	147;144;144	A;G;T	145;141;139	parC.WHO_L_00611c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_L_00611c	parC.WHO_L_00611c	1	1	27	4308	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2889	147.6	1	SNP	p	S87W	0	.	.	259	261	AGT	538	540	AGT	147;144;144	A;G;T	145;141;139	parC.WHO_L_00611c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_L_00611c	parC.WHO_L_00611c	1	1	27	4308	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2889	147.6	1	SNP	p	S87R	0	.	.	259	261	AGT	538	540	AGT	147;144;144	A;G;T	145;141;139	parC.WHO_L_00611c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3146	parE	1986	1986	99.95	parE.l15.c30.ctg.1	2727	114.6	0	.	p	.	0	P456S	NONSYN	1366	1368	CCC	1761	1763	TCC	144;143;143	T;C;C	138;141;139	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3146	parE	1986	1986	99.95	parE.l15.c30.ctg.1	2727	114.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1623	1625	GGC	157;156;158	G;G;C	154;153;153	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.43.002	penA.43.002	1	1	27	3308	penA	1749	1749	99.94	penA.l15.c30.ctg.1	2351	138.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1344	1346	GCA	164;162;164	G;C,T;A	155;152,1;158	penA.43.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	3308	penA	1749	1749	99.94	penA.l15.c30.ctg.1	2351	138.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1347	1349	ATC	166;166;167	A;T,A;C	160;158,1;160	penA.43.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	3308	penA	1749	1749	99.94	penA.l15.c30.ctg.1	2351	138.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1359	1361	GTG	175;173;173	G;T;G	168;164;167	penA.43.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	3308	penA	1749	1749	99.94	penA.l15.c30.ctg.1	2351	138.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1359	1361	GTG	175;173;173	G;T;G	168;164;167	penA.43.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	3308	penA	1749	1749	99.94	penA.l15.c30.ctg.1	2351	138.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1863	1865	ACC	170;169;171	A;C;C,T	160;165;164,1	penA.43.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	3308	penA	1749	1749	99.94	penA.l15.c30.ctg.1	2351	138.4	1	SNP	p	A502V	1	.	.	1504	1506	GTG	1917	1919	GTG	148;146;145	G;T,G;G	141;120,3;141	penA.43.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	3308	penA	1749	1749	99.94	penA.l15.c30.ctg.1	2351	138.4	1	SNP	p	V502P	0	.	.	1504	1506	GTG	1917	1919	GTG	148;146;145	G;T,G;G	141;120,3;141	penA.43.002:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	3308	penA	1749	1749	99.94	penA.l15.c30.ctg.1	2351	138.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2040	2042	GGC	132;131;131	G;G;C	131;129;129	penA.43.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	3308	penA	1749	1749	99.94	penA.l15.c30.ctg.1	2351	138.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2049	2051	GGC	122;120;120	G;G;C	120;117;118	penA.43.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	3308	penA	1749	1749	99.94	penA.l15.c30.ctg.1	2351	138.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2067	2069	CCG	87;90;88	C,G;C,G;G	77,2;79,1;74	penA.43.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4824	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3118	153.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1640	1642	CCG	165;167;165	C;C;G	155;159;156	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1916	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1662	114.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	329	331	GGC	134;132;133	G;G;C	128;127;126	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1916	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1662	114.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	511	511	C	143	C	139	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2460	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1479	164.4	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	647	649	AAG	193;193;195	A;A;G	185;183;189	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2460	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1479	164.4	0	.	p	.	0	D121G	NONSYN	361	363	GAC	650	652	GGC	198;197;199	G;G;C	187;187;186	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2460	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1479	164.4	0	.	p	.	0	E212D	NONSYN	634	636	GAA	923	925	GAT	230;232;230	G;A;T	224;227;220	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2460	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1479	164.4	0	.	p	.	0	H213G	NONSYN	637	639	CAT	926	928	GGT	230;225;223	G;G;T	223;220;207	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2460	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1479	164.4	0	.	p	.	0	V215A	NONSYN	643	645	GTT	932	934	GCT	223;222;224	G;C;T	215;216;218	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2460	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1479	164.4	0	.	p	.	0	I218M	NONSYN	652	654	ATC	941	943	ATG	214;211;210	A;T;G	209;208;203	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2460	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1479	164.4	0	.	p	.	0	R257T	NONSYN	769	771	AGG	1058	1060	ACG	204;202;201	A;C,T;G	199;196,1;198	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2460	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1479	164.4	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1064	1066	GTT	205;205;202	G;T,A;T	199;199,1;194	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2460	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1479	164.4	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1178	1180	AAC	187;186;189	A;A;C	179;178;182	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8906	rpoB	4179	4179	99.95	rpoB.l15.c17.ctg.1	4793	184.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1022	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	922	109.3	1	SNP	p	V57M	1	.	.	169	171	ATG	511	513	ATG	206;209;210	A;T;G	201;201;206	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	11904	tetM	1920	1920	100.0	tetM.l15.c4.ctg.1	2466	477.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
